BioCeramic Therapeutics Receives New Investment of £1.2m

London, 20 October 2009 … BioCeramic Therapeutics (BCT), an emerging leader in the field of novel biomaterials for healthcare, has received £1.2 million of new investment as the Company prepares to commercialise its products in 2010.

Imperial Innovations has invested £300,000 and Longbow Capital, a new investor, has invested £400,000. Other investors in the round include Comvest Limited and the Esmee Fairbairn Foundation, both of whom are existing shareholders. In addition, Mark Rowan, a director of Imperial Innovations and a director of, and existing shareholder in, BioCeramic Therapeutics, has invested a further £20,000 in the round. This investment follows funding of £1.04 million in 2007.

BioCeramic Therapeutics has also recently appointed Dr Stephan Rietiker, a recognised leader in the global medical health sector, as Chairman.

BioCeramic Therapeutics is developing bioactive materials for orthopaedic and dental applications. Its first products are scheduled for launch in 2010 and include bone graft substitutes that will help treat bone diseases and difficult fractures.

"This cash injection is a huge vote of confidence by our investors on BioCeramic Therapeutic's ability to deliver. It will enable the company to move into its next phase and grow into a commercial, cash generating business," says Dr Stephan Rietiker, MD.

-ends-

About BioCeramic Therapeutics Limited

BCT is a pioneer in the exciting new field of regenerative medicine, bringing together some of the world’s best materials scientists, doctors, biologists and chemists in both private and public sectors. BCT is developing two families of implants designed to promote tissue regeneration. Initial applications are in orthopaedics and oral care, with plans to extend this to a wide range of other tissues important in human diseases. Please visit:  www.bioceramictherapeutics.com.

For further information, please contact:

College Hill                                                                                            BioCeramic Therapeutics
Tony Stephenson, Benjamyn Tan, Sue Charles                            Daniel Green
Tel: +44 (0)20 7866 7864                                                                   Tel: +44 (0)20 7594 1326
E-mail: tony.stephenson@collegehill.com                                     Email : djg@bioceramictherapeutics.com